The impact of hemoglobin levels on treatment outcomes in patients with cancer

Seminars in Oncology

Volumn 28, Issue 2 SUPPL. 8, 2001, Pages 49-53

  Littlewood, Timothy J ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; DRUG EFFICACY; HEMOGLOBIN DETERMINATION; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 0034989312     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2001.25397     Document Type: Article

References (35)

1. Chemotherapy-induced anemia in adults: Incidence and treatment
2. A new staging system for multiple myeloma based on the number of S-phase plasma cells
3. Anemia associated with non-platinum chemotherapy (CT) for Hodgkin's lymphoma (HL) or non-Hodgkin's lymphoma (NHL)
4. Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy
5. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice
6. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study
7. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial
8. Survival determinants in extensive-stage non-small-cell lung cancer: The Southwest Oncology Group experience
9. Prognostic factors for survival in inoperable non-small cell lung cancer
10. Relevance of oxygen in radiation oncology. Mechanisms of action, correlation to low hemoglobin levels
11. Blood flow, oxygenation and bioenergetic status of tumors after erythropoietin treatment in normal and anemic rats
12. Association between tumour hypoxia and malignant progression in advanced cancer of the uterine cervix
13. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck
14. Association between tumor hypoxia and malignant progression: The clinical evidence in cancer of the uterine cervix
15. The oxygen effect and reoxygenation
16. The impact of blood hemoglobin content on the outcome of radiotherapy. The Freiburg experience
17. Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: Results of a retrospective study of 386 patients
18. Radiotherapy and anaemia - The clinical experience
19. The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinoma
20. Prognostic value of hemoglobin concentration in radiotherapy for cancer of supraglottic larynx
21. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: A secondary analysis of RTOG 85-27
22. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix
23. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review
24. Does p53 status influence tumor response to anticancer therapies?
25. Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma
26. Transfusion medicine. First of two parts - Blood transfusion
27. Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer
28. Clinical evaluation of once-weekly dosing of eopetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life similar to three-times-weekly dosing
29. Erythropoietin increases hemoglobin in cancer patients during radiation therapy
30. Clinical trial experience using erythropoietin during radiation therapy
31. Erythropoietin increases hemoglobin during radiation therapy for cervical cancer
32. Effect of the administration of recombinant human erythropoietin in patients with pelvic malignancies during radiotherapy
33. r-HuErythropoietin supply increases efficacy of neoadjuvant radiochemotherapy in patients with oral squamous cell carcinoma
34. Once-weekly dosing of epoetin alfa increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy
35. r-HuErythropoietin treatment increases efficacy of neoadjuvant radiochemotherapy and improves cancer free survival of patients with oral squamous cell carcinoma: A 17 month follow up